A Randomized Controlled Clinical study of Shunthi Bidalak in Simple Allergic Conjunctivitis
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 56
- Locations
- 1
- Primary Endpoint
- Reduction of Itching.
Study Overview
Brief Summary
This study is a randomized controlled , open label , parallel group study on efficacy of Shunthi Bidalak in
Simple Allergic Conjunctivitis for 14 days in 30 patients with simple allergic conjunctivitis that will be conducted in Bharati Vidyapeeth (Deemed to be University), College of Ayurved and Hospital, Department of Shalakya Tantra, OPD number 24, Katraj, Dhankawadi, Pune
- The primary outcome measures will be Reduction of Itching,Burning sensation,Redness,Photophobia and Lacrimation.
Study Design
- Study Type
- Interventional
- Allocation
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
Inclusion Criteria
- •Participants suffering from Simple Allergic Conjunctivitis.
- •1 Age 18 to 60 years 2 Gender Both male and female.
Exclusion Criteria
- •1 Participants suffering from ocular surface pathology.
- •2 post-operative participants.
- •3 Participants suffering from all other type of conjunctivitis.
Outcomes
Primary Outcomes
Reduction of Itching.
Time Frame: 14 days
Reduction of Burning sensation.
Time Frame: 14 days
Reduction of Redness.
Time Frame: 14 days
Reduction of Photophobia.
Time Frame: 14 days
Reduction of Lacrimation.
Time Frame: 14 days
Secondary Outcomes
- Relief From Signs And Symptoms(1 year)
Investigators
Dr Mayur Nakade
Bharati Vidyapeeth (Deemed To be University ) , College of Ayurveda, Pune-43
